Immunoepigenetics Combination Therapies: An Overview of the Role of HDACs in Cancer ImmunotherapyDebarati Banik(George Washington University), Alejandro Villagra(Georgetown University)International Journal of Molecular SciencesMay 7, 201910.3390/ijms20092241Cited by 149SaveCiteExport RISWatch citationsRelated PapersSelective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells|Scientific Reports|2019|160The HDAC6 inhibitor AVS100 (SS208) induces a pro-inflammatory tumor microenvironment and potentiates immunotherapy|Science Advances|2024|23